Johnson & Johnson Has New $6.5B Plan To Resolve Asbestos Talc Claims
NEW BRUNSWICK, N.J. — Johnson & Johnson (J&J) announced May 1 that it will pay nearly $6.5 billion to resolve all ovarian cancer claims through a prepackaged plan of reorganization for...To view the full article, register now.
Already a subscriber? Click here to view full article